OZEM vs. LABD ETF Comparison

Comparison of Roundhill GLP-1 & Weight Loss ETF (OZEM) to Direxion Daily S&P Biotech Bear 3X Shares (LABD)
OZEM

Roundhill GLP-1 & Weight Loss ETF

OZEM Description

OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.

Grade (RS Rating)

Last Trade

$27.32

Average Daily Volume

31,803

Number of Holdings *

14

* may have additional holdings in another (foreign) market
LABD

Direxion Daily S&P Biotech Bear 3X Shares

LABD Description The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the S&P Biotechnology Select Industry Index. The index is provided by Standard & Poor's and includes domestic companies from the biotechnology industry. The fund normally creates short positions by investing at least 80% of its assets in: swap agreements; options on securities and indices; forward contracts; short positions; reverse repurchase agreements; ETFs; and other financial instruments that, in combination, provide inverse leveraged and unleveraged exposure to the S&P Biotechnology Select Industry Index ("index"). It is non-diversified.

Grade (RS Rating)

Last Trade

$5.76

Average Daily Volume

15,699,334

Number of Holdings *

79

* may have additional holdings in another (foreign) market
Performance
Period OZEM LABD
30 Days -0.27% -3.36%
60 Days -5.30% 6.17%
90 Days 3.02% -9.66%
12 Months -75.44%
4 Overlapping Holdings
Symbol Grade Weight in OZEM Weight in LABD Overlap
AMGN C 3.25% 1.75% 1.75%
OPK C 1.35% 0.35% 0.35%
REGN F 2.61% 1.77% 1.77%
VKTX A 3.69% 0.38% 0.38%
OZEM Overweight 10 Positions Relative to LABD
Symbol Grade Weight
NVO F 17.47%
LLY F 15.52%
AZN F 4.28%
ALT D 3.69%
PFE D 3.15%
SRRK B 2.62%
TERN D 2.14%
TAK C 1.96%
RYTM D 1.7%
CORT B 1.43%
OZEM Underweight 75 Positions Relative to LABD
Symbol Grade Weight
EXEL A -1.91%
BMRN F -1.89%
BLUE F -1.87%
VRTX D -1.84%
SAGE F -1.8%
UTHR A -1.78%
ALNY C -1.73%
EXAS A -1.73%
ABBV A -1.72%
ACAD F -1.68%
SRPT D -1.66%
BIIB F -1.65%
IONS F -1.64%
GILD A -1.64%
NBIX C -1.62%
BPMC C -1.61%
INCY A -1.51%
RARE D -1.49%
MRNA F -1.47%
LGND A -1.46%
ARWR F -1.45%
BHVN B -1.42%
PTCT B -1.4%
FOLD B -1.38%
AGIO B -1.37%
APLS F -1.24%
ALKS F -1.21%
MYGN F -1.08%
NTRA B -1.08%
IOVA B -1.07%
FGEN F -1.05%
RGNX F -1.05%
CHRS F -0.99%
EBS B -0.96%
CDNA D -0.93%
HRTX F -0.84%
INSM D -0.81%
KPTI C -0.79%
ESPR C -0.79%
ALLK B -0.76%
IRWD F -0.75%
VCYT A -0.72%
HALO B -0.71%
FATE F -0.67%
EDIT F -0.66%
PBYI C -0.65%
MDGL A -0.59%
TGTX A -0.55%
ADVM D -0.55%
ALLO D -0.54%
CPRX A -0.53%
ANAB F -0.53%
XNCR A -0.49%
SGMO A -0.48%
ENTA D -0.47%
EGRX F -0.42%
GTHX A -0.42%
ATRA C -0.41%
ANIK F -0.37%
VNDA D -0.35%
VCEL D -0.34%
TVTX B -0.33%
KOD B -0.29%
BBIO D -0.29%
NTLA F -0.29%
PGEN F -0.29%
DNLI C -0.28%
KRYS C -0.28%
GOSS F -0.27%
VYGR C -0.26%
MGNX C -0.25%
ALEC D -0.25%
CYTK F -0.25%
DVAX A -0.24%
YMAB A -0.24%
Compare ETFs